Aditxt earnings were -$54.7M for the trailing 12 months ending Mar 31, 2026, with -100% growth year over year. The latest ADTX earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$15.9M, up 113.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ADTX reported annual earnings of -$44.5M, with -3.8% growth.
ADTX past earnings growth
How has ADTX's earnings growth performed historically?
Aditxt (NASDAQ: ADTX) reported Q1 2026 earnings per share (EPS) of -$790.49, up 99.6% year over year. Total ADTX earnings for the quarter were -$15.95 million. In the same quarter last year, Aditxt's earnings per share (EPS) was -$198,072.98.
As of the last Aditxt earnings report, Aditxt is currently losing money. Aditxt's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$53.34 million, a 70.23% increase year over year.
What was ADTX's earnings growth in the past year?
As of Aditxt's earnings date in Q2 2026, Aditxt's earnings has grown -99.99% year over year. This is 152.95 percentage points lower than the US Biotechnology industry earnings growth rate of 52.95%. ADTX earnings in the past year totalled -$54.73 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.